From DCAT Value Chain Insights (VCI)
FDA has issued a Broad Agency Announcement (BAA) for soliciting research and development to support regulatory science and innovation, which includes innovation in manufacturing. The BAA fulfills an FDA requirement to use industry capabilities for advancing and achieving improvements in technology, materials, processes, methods, devices, or techniques for specific topics, and the agency has selected nine topics, which includes manufacturing. The nine areas of focus of the BAA are to:
With respect to manufacturing, FDA is seeking to support the application of novel technologies to product development and innovative analytical approaches to improve product manufacturing and quality through active research intramural and collaboratively with external partners. With respect to manufacturing, the agency wants to:
The agency also wants to develop ways to reduce risk of microbial contamination of products with two areas of specific interest to:
Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT).
Learn more and sign up to receive a complimentary subscription